According to 99Strategy, the Global Opioid-induced Constipation Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Opioid-induced Constipation market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance
Key Product Type
Solid
Liquid
Market by Application
Drugstore
Hospital
Others
Main Aspects covered in the Report
Overview of the Opioid-induced Constipation market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Abbott
Bayer
Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daewoong
Daiichi Sankyo
GlaxoSmithKline
Ironwood Pharmaceuticals
Johnson & Johnson
Merck
Mundipharma
Nektar Therapeutics
Pfizer
Progenics Pharmaceuticals
Shionogi
SLA Pharma
Sucampo
Synergy Pharmaceuticals
Theravance
Key Product Type
Solid
Liquid
Market by Application
Drugstore
Hospital
Others
Main Aspects covered in the Report
Overview of the Opioid-induced Constipation market including production, consumption, status & forecast and market growth
2017-2021 historical data and 2022-2027 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Table of Content
1 Industrial Chain Overview
1.1 Opioid-induced Constipation Industry
1.1.1 Overview
Figure Opioid-induced Constipation Picture List
1.1.2 Characteristics of Opioid-induced Constipation
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Solid
1.3.2 Liquid
1.4 End-Use List
1.4.1 Demand in Drugstore
1.4.2 Demand in Hospital
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 AstraZeneca Overview
Table AstraZeneca Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Takeda Pharmaceutical Overview
Table Takeda Pharmaceutical Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Takeda Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Valeant Pharmaceuticals International Overview
Table Valeant Pharmaceuticals International Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Abbott Overview
Table Abbott Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Abbott (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Bayer Overview
Table Bayer Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Boehringer Ingelheim Overview
Table Boehringer Ingelheim Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 C.B. Fleet Overview
Table C.B. Fleet Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of C.B. Fleet (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Cosmo Pharmaceuticals Overview
Table Cosmo Pharmaceuticals Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Cosmo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Daewoong Overview
Table Daewoong Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Daewoong (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Daiichi Sankyo Overview
Table Daiichi Sankyo Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 GlaxoSmithKline Overview
Table GlaxoSmithKline Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Ironwood Pharmaceuticals Overview
Table Ironwood Pharmaceuticals Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Ironwood Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Merck Overview
Table Merck Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Mundipharma Overview
Table Mundipharma Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Mundipharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Nektar Therapeutics Overview
Table Nektar Therapeutics Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Pfizer Overview
Table Pfizer Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Progenics Pharmaceuticals Overview
Table Progenics Pharmaceuticals Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Progenics Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Shionogi Overview
Table Shionogi Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Shionogi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 SLA Pharma Overview
Table SLA Pharma Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of SLA Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Sucampo Overview
Table Sucampo Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Sucampo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Synergy Pharmaceuticals Overview
Table Synergy Pharmaceuticals Overview List
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Synergy Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
3.2.23 Theravance Overview
Table Theravance Overview List
3.2.23.1 Product Specifications
3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Theravance (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.23.3 Recent Developments
3.2.23.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Solid
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Solid, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Solid, 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Liquid
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Liquid, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Liquid, 2017-2021, in Volume
5.2.2.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Drugstore
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Drugstore, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Drugstore, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Hospital
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Hospital, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Hospital, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Opioid-induced Constipation Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion
1 Industrial Chain Overview
1.1 Opioid-induced Constipation Industry
1.1.1 Overview
Figure Opioid-induced Constipation Picture List
1.1.2 Characteristics of Opioid-induced Constipation
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Type
1.3.1 Solid
1.3.2 Liquid
1.4 End-Use List
1.4.1 Demand in Drugstore
1.4.2 Demand in Hospital
1.4.3 Demand in Others
1.5 Global Market Overview
1.5.1 Global Market Size and Forecast, 2017-2027
Figure Global Market Size and Forecast with Growth Rate, 2017-2027
1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027
Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027
1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027
Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027
1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027
Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD
2.1.2 Global Consumption
Figure Global Market Volume and Growth Rate, 2017-2021, in Volume
Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume
Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD
Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.2 North America
Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.3 South America
Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume
Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.4 Europe
Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.1.5 Middle East & Africa
Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD
2.2.2 Consumption
2.2.2.1 Asia-Pacific
Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume
Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD
Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.2 North America
Figure North America Market Volume and Growth Rate, 2017-2021, in Volume
Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD
Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.3 South America
Figure South America Market Volume and Growth Rate, 2017-2021, in Volume
Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD
Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.4 Europe
Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume
Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD
Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD
2.2.2.5 Middle East & Africa
Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume
Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD
Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2021
3.2 Manufacturers List
3.2.1 AstraZeneca Overview
Table AstraZeneca Overview List
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of AstraZeneca (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Takeda Pharmaceutical Overview
Table Takeda Pharmaceutical Overview List
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Takeda Pharmaceutical (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Valeant Pharmaceuticals International Overview
Table Valeant Pharmaceuticals International Overview List
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Valeant Pharmaceuticals International (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Abbott Overview
Table Abbott Overview List
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Abbott (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Bayer Overview
Table Bayer Overview List
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Bayer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Boehringer Ingelheim Overview
Table Boehringer Ingelheim Overview List
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 C.B. Fleet Overview
Table C.B. Fleet Overview List
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of C.B. Fleet (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Cosmo Pharmaceuticals Overview
Table Cosmo Pharmaceuticals Overview List
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Cosmo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Daewoong Overview
Table Daewoong Overview List
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Daewoong (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Daiichi Sankyo Overview
Table Daiichi Sankyo Overview List
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Daiichi Sankyo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 GlaxoSmithKline Overview
Table GlaxoSmithKline Overview List
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of GlaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Ironwood Pharmaceuticals Overview
Table Ironwood Pharmaceuticals Overview List
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Ironwood Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Johnson & Johnson Overview
Table Johnson & Johnson Overview List
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Merck Overview
Table Merck Overview List
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
3.2.15 Mundipharma Overview
Table Mundipharma Overview List
3.2.15.1 Product Specifications
3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Mundipharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.15.3 Recent Developments
3.2.15.4 Future Strategic Planning
3.2.16 Nektar Therapeutics Overview
Table Nektar Therapeutics Overview List
3.2.16.1 Product Specifications
3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Nektar Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.16.3 Recent Developments
3.2.16.4 Future Strategic Planning
3.2.17 Pfizer Overview
Table Pfizer Overview List
3.2.17.1 Product Specifications
3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.17.3 Recent Developments
3.2.17.4 Future Strategic Planning
3.2.18 Progenics Pharmaceuticals Overview
Table Progenics Pharmaceuticals Overview List
3.2.18.1 Product Specifications
3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Progenics Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.18.3 Recent Developments
3.2.18.4 Future Strategic Planning
3.2.19 Shionogi Overview
Table Shionogi Overview List
3.2.19.1 Product Specifications
3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Shionogi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.19.3 Recent Developments
3.2.19.4 Future Strategic Planning
3.2.20 SLA Pharma Overview
Table SLA Pharma Overview List
3.2.20.1 Product Specifications
3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of SLA Pharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.20.3 Recent Developments
3.2.20.4 Future Strategic Planning
3.2.21 Sucampo Overview
Table Sucampo Overview List
3.2.21.1 Product Specifications
3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Sucampo (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.21.3 Recent Developments
3.2.21.4 Future Strategic Planning
3.2.22 Synergy Pharmaceuticals Overview
Table Synergy Pharmaceuticals Overview List
3.2.22.1 Product Specifications
3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Synergy Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.22.3 Recent Developments
3.2.22.4 Future Strategic Planning
3.2.23 Theravance Overview
Table Theravance Overview List
3.2.23.1 Product Specifications
3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
Table Opioid-induced Constipation Business Operation of Theravance (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
3.2.23.3 Recent Developments
3.2.23.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
Figure Global Market Size and Growth Rate, 2017-2021, in Volume
Figure Global Market Size and Growth Rate, 2017-2021, in Million USD
Figure Global Competition Sketch Overview
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
Table Global Production Volume List by Manufacturers, 2017-2021, in Volume
Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume
Figure Global Production Volume Share by Manufacturers in 2021, in Volume
Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD
Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD
Figure Global Production Amount Share by Manufacturers in 2021, in Million USD
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume
5.2 Segment Subdivision by Product Type
5.2.1 Market in Solid
5.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Solid, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Solid, 2017-2021, in Volume
5.2.1.2 Situation & Development
5.2.2 Market in Liquid
5.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Liquid, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Liquid, 2017-2021, in Volume
5.2.2.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume
6.2 Segment Subdivision
6.2.1 Market in Drugstore
6.2.1.1 Market Size
Figure Global Market Amount and Growth Rate in Drugstore, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Drugstore, 2017-2021, in Volume
6.2.1.2 Situation & Development
6.2.2 Market in Hospital
6.2.2.1 Market Size
Figure Global Market Amount and Growth Rate in Hospital, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Hospital, 2017-2021, in Volume
6.2.2.2 Situation & Development
6.2.3 Market in Others
6.2.3.1 Market Size
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
Table Global Market Forecast by Region Segment 2022-2027, in Million USD
Table Global Market Forecast by Region Segment 2022-2027, in Volume
7.2 Consumption Forecast
7.2.1 Product Type Forecast
Table Global Market Amount by Product Type Segment 2022-2027, in Million USD
Table Global Market Volume by Product Type Segment 2022-2027, in Volume
7.2.2 End-Use Forecast
Table Global Market Amount by End-Use Segment 2022-2027, in Million USD
Table Global Market Volume by End-Use Segment 2022-2027, in Volume
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
Figure Cost Component Ratio
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
9.3 Impact of Coronavirus on the Opioid-induced Constipation Industry
9.3.1 Impact on Industry Upstream
9.3.2 Impact on Industry Downstream
9.3.3 Impact on Industry Channels
9.3.4 Impact on Industry Competition
9.3.5 Impact on Industry Employment
10 Research Conclusion